ROW — Total revenues
United Therapeutics ROW — Total revenues decreased by 0.3% to $37.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.7%, from $44.80M to $37.30M. Over 4 years (FY 2021 to FY 2025), ROW — Total revenues shows an upward trend with a 4.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful international market expansion and growing global demand for the company's therapeutic portfolio, while a decrease may signal competitive pressures or regulatory hurdles in foreign markets.
Detailed definition
This metric represents the total gross revenue generated from sales of pharmaceutical products and services within geogr...
Peer comparison
Comparable to international revenue or non-domestic segment sales reported by other global pharmaceutical and biotechnology firms.
uthr_segment_row_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $34.80M | $32.60M | $29.10M | $52.10M | $26.50M | $15.80M | $27.80M | $37.20M | $34.50M | $24.80M | $28.80M | $36.20M | $39.70M | $31.60M | $30.20M | $44.80M | $38.80M | $24.70M | $37.40M | $37.30M |
| QoQ Change | — | -6.3% | -10.7% | +79.0% | -49.1% | -40.4% | +75.9% | +33.8% | -7.3% | -28.1% | +16.1% | +25.7% | +9.7% | -20.4% | -4.4% | +48.3% | -13.4% | -36.3% | +51.4% | -0.3% |
| YoY Change | — | — | — | — | -23.9% | -51.5% | -4.5% | -28.6% | +30.2% | +57.0% | +3.6% | -2.7% | +15.1% | +27.4% | +4.9% | +23.8% | -2.3% | -21.8% | +23.8% | -16.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's row — total revenues?
- United Therapeutics (UTHR) reported row — total revenues of $37.30M in Q1 2026.
- How has United Therapeutics's row — total revenues changed year-over-year?
- United Therapeutics's row — total revenues decreased by 16.7% year-over-year, from $44.80M to $37.30M.
- What is the long-term trend for United Therapeutics's row — total revenues?
- Over 4 years (2021 to 2025), United Therapeutics's row — total revenues has grown at a 4.7% compound annual growth rate (CAGR), from $121.30M to $145.70M.
- What does row — total revenues mean?
- Total sales revenue generated from all geographic regions outside of the company's home country.